Volume 5 , Issue 2 : Special Issue CITCOVID-19 , PP: PP. 21-22, 2021 | Cite this article as | XML | Html | PDF | Short review
Ahmed A. Elngar 1 * , S.I. El-Dek 2
Doi: https://doi.org/10.54216/JCIM.050203
We introduce our idea about a new face mask against Covid-19. Herein our novel face mask is a polymeric matrix of nanofibers. These nanofibers are decorated with special engineered nanocomposite. The later possesses antiviral, antimicrobial. Awell-established IR temperature biosensor will be implanted in the face mask and connected to the mobile phone using App (Seek thermal) to allow temperature monitoring. Artificial Intelligence can play a vital role in the fight against COVID-19. AI is being successfully used in the identification of disease clusters, monitoring of cases, prediction of the future outbreaks, mortality risk, diagnosis of COVID-19, disease management by resource allocation, facilitating training, record maintenance and pattern recognition for studying the disease trend. Therefore, AI is used as a type of alarm which be connected through Global Position System (GPS) to a central networking system to monitor the crowded areas of probable infections. In this case, the hospital in this neighborhood will be charged to let a mobile unit of assessment travel quickly to the infected people areas.
Covid-19, Nanofibers, Face Mask, Artificial Intelligent, Nanocomposite, Engineered
[1] O’Dowd, K.; Nair, K.M.; Forouzandeh, P.; Mathew, S.; Grant, J.; Moran, R.; Bartlett, J.; Bird, J.; Pillai, S.C. Face masks and respirators in the fight against the COVID-19 pandemic: A review of current materials, advances and future perspectives. Materials 2020, 13, 3363.
[2] Chua, M.H.; Cheng, W.; Goh, S.S.; Kong, J.; Li, B.; Lim, J.Y.C.; Mao, L.; Wang, S.; Xue, K.; Yang, L.; et al. Face Masks in the New COVID-19 Normal: Materials, Testing, and Perspectives. Research 2020, 2020, 7286735.
[3] Randhawa GS, Soltysiak MP, El Roz H et al. Machine learning using intrinsic genomic signatures for rapid classification of novel pathogens: COVID-19 case study. PLoS ONE 15(4), e0232391 (2020).
[4] Abdulla A, Wang B, Qian F et al. Project IDentif. AI: harnessing artificial intelligence to rapidly optimize combination therapy development for infectious disease intervention. Adv. Ther. 3(7), 2000034 (2020).
